CMPNY

US FDA gives first-ever approval to fecal transplant therapy

Nov 30 (Reuters) – The US health regulator on Wednesday approved Switzerland-based Ferring Pharmaceuticals’ fecal transplant-based therapy to reduce the recurrence of a bacterial infection, making it the first therapy of its kind to be cleared in the United States. The therapy, Rebyota, targets Clostridium difficile, or C. difficile – a superbug responsible for infections …

US FDA gives first-ever approval to fecal transplant therapy Read More »

US FDA approves Rigel Pharma’s treatment for a type of leukemia

Dec 1 (Reuters) – Rigel Pharmaceuticals (RIGL.O) said on Thursday the US health regulator has approved its drug for the treatment of patients with a type of leukemia, sending its shares up 14% in extended trading. The Food and Drug Administration approved the drug, which will be sold under the brand Rezlidhia, for the treatment …

US FDA approves Rigel Pharma’s treatment for a type of leukemia Read More »

Roivant, Pfizer team up on inflammatory disease drug

Dec 1 (Reuters) – Biotech firm Roivant Sciences (ROIV.O) on Thursday launched a company with Pfizer Inc (PFE.N) focused on an experimental bowel disease treatment, as the drugmakers seek to tap into a multibillion dollar market. The drug, RVT-3101, was originally developed by Pfizer, which will hold a 25% stake in the new business, with …

Roivant, Pfizer team up on inflammatory disease drug Read More »

US FDA gives first-ever approval to fecal transplant therapy

Nov 30 (Reuters) – The US health regulator on Wednesday approved Switzerland-based Ferring Pharmaceuticals’ fecal transplant-based therapy to reduce the recurrence of a bacterial infection, making it the first therapy of its kind to be cleared in the United States. The therapy, Rebyota, targets Clostridium difficile, or C. difficile – a superbug responsible for infections …

US FDA gives first-ever approval to fecal transplant therapy Read More »

FDA pulls US authorization for Eli Lilly’s COVID drug bebtelovimab

Nov 30 (Reuters) – Eli Lilly and Co’s COVID-19 drug bebtelovimab is not currently authorized for emergency use in the United States, the Food and Drug Administration said, citing it is not expected to neutralize the dominant BQ.1 and BQ.1.1 subvariants of Omicron. Wednesday’s announcement takes away authorization from the last COVID-19 monoclonal antibody treatment, …

FDA pulls US authorization for Eli Lilly’s COVID drug bebtelovimab Read More »

Rare success for Alzheimer’s research unlocks hope for future therapies

CHICAGO, Nov 29 (Reuters) – The first big breakthrough in 30 years of Alzheimer’s research is providing momentum for clinical trials of “cocktail” treatments targeting the two hallmark proteins associated with the mind-robbing disease, according to interviews with researchers and pharmaceutical executives . Drugmakers Eisai Co Ltd (4523.T) and Biogen (BIIB.O) reported in September that …

Rare success for Alzheimer’s research unlocks hope for future therapies Read More »

Brazil’s transition team asks Petrobras CEO to suspend company’s divestment plan

RIO DE JANEIRO, Nov 28 (Reuters) – Brazil’s government-elected transition team asked state-run oil company Petrobras’ (PETR4.SA) Chief Executive, Caio Mario Paes de Andrade, to suspend the company’s divestment plan so they have time to decide which asset sales would go ahead in the coming years, transition team member Mauricio Tolmasquim told Reuters on Monday. …

Brazil’s transition team asks Petrobras CEO to suspend company’s divestment plan Read More »

Wall St losses limited as Amazon gains on upbeat Cyber ​​Monday

Cyber ​​Monday spends to hit record $11.6 bln – report Biogen down after death in Alzheimer drug trial Indexes off: Dow 0.47%, S&P 0.60%, Nasdaq 0.35% Nov 28 (Reuters) – Wall Street’s main indexes fell on Monday amid worries about protests in major Chinese cities against strict COVID-19 policies, although gains in Amazon helped limit …

Wall St losses limited as Amazon gains on upbeat Cyber ​​Monday Read More »